MCL Clinical Trials

1230 trials from ClinicalTrials.gov. Recruiting trials shown first.

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

NCT00004084·PHASE1 / PHASE2·Garden State Cancer Center at the Center for Molecular Medicine and Immunology·21 enrolled

indium In 111 LL2 IgGyttrium Y 90 epratuzumab

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

NCT00003395·PHASE1·Memorial Sloan Kettering Cancer Center

arsenic trioxide

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

NCT00003408·PHASE2·Cancer Treatment Centers of America·40 enrolled

aldesleukinrecombinant interferon alfasargramostim

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00003245·PHASE2·M.D. Anderson Cancer Center·50 enrolled

irinotecan hydrochloride

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00003269·PHASE2·Scripps Health·20 enrolled

sargramostimamifostine trihydratecisplatincyclophosphamideetoposide

Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma

NCT00586755·PHASE2·Duke University·48 enrolled

Intensive Induction-BMT

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

NCT00005626·PHASE2·H. Lee Moffitt Cancer Center and Research Institute·10 enrolled

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

NCT00004107·PHASE1 / PHASE2·Garden State Cancer Center at the Center for Molecular Medicine and Immunology·18 enrolled

filgrastimautologous bone marrow transplantationperipheral blood stem cell transplantationindium In 111 monoclonal antibody MN-14yttrium Y 90 epratuzumab

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

NCT00002779·PHASE2·Alliance for Clinical Trials in Oncology·34 enrolled

fludarabine phosphateoctreotide acetate

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00003210·PHASE2·National Cancer Institute (NCI)·105 enrolled

recombinant interleukin-12laboratory biomarker analysis

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

NCT00003280·PHASE3·Swiss Cancer Institute·240 enrolled

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

NCT00003335·PHASE2·Case Comprehensive Cancer Center·44 enrolled

anti-thymocyte globulinbusulfancyclosporinemelphalanmethylprednisolone+2 more

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

NCT00006368·PHASE1·Novartis Pharmaceuticals·60 enrolled

yttrium Y 90-edotreotide

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00003331·PHASE1·NYU Langone Health·30 enrolled

fluorouracilleucovorin calciumtopotecan hydrochloride

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

NCT00003082·PHASE1·University of Arizona·27 enrolled

monoclonal antibody A27.15monoclonal antibody E2.3

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

NCT00003425·PHASE1 / PHASE2·University of Kentucky·25 enrolled

filgrastimamifostine trihydratecyclophosphamidemelphalanperipheral blood stem cell transplantation

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

NCT00003341·PHASE3·Memorial Sloan Kettering Cancer Center·275 enrolled

epoetin alfaquality-of-life assessment

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805·PHASE3·European Organisation for Research and Treatment of Cancer - EORTC·859 enrolled

piperacillin sodiumpiperacillin-tazobactamtazobactam sodiumvancomycin

Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma

NCT00003356·PHASE1 / PHASE2·University of Rochester·58 enrolled

aldesleukinrituximab

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

NCT00003143·PHASE2·Jonsson Comprehensive Cancer Center·20 enrolled

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma

NCT00003885·PHASE2·Our Lady of Mercy Medical Center·60 enrolled

arsenic trioxide

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

NCT00004036·PHASE1·The Cleveland Clinic·30 enrolled

sargramostimamifostine trihydratecarboplatincyclophosphamide

Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma

NCT00225212·PHASE2·Stanford University·35 enrolled

Rituximab 375 mg/m2

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

NCT00003406·PHASE1 / PHASE2·Cancer Treatment Centers of America·30 enrolled

carboplatindocetaxelifosfamideautologous bone marrow transplantationbone marrow ablation with stem cell support+1 more

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

NCT00002946·PHASE1·National Cancer Institute (NCI)·30 enrolled

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107·PHASE1·Indiana University School of Medicine

recombinant interleukin-12

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

NCT00003414·PHASE3·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·50 enrolled

aldesleukinrecombinant interferon gammabusulfancyclophosphamidecyclosporine+2 more

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003270·PHASE2·Roswell Park Cancer Institute·20 enrolled

anti-thymocyte globulinfilgrastimbusulfancyclophosphamidecyclosporine+4 more

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

NCT00003196·NA·Fred Hutchinson Cancer Center·63 enrolled

chemotherapytotal-body irradiationperipheral blood stem cell transplantationcyclosporinemycophenolate mofetil+2 more

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

NCT00003039·PHASE2·National Cancer Institute (NCI)·40 enrolled

← PreviousPage 39 of 41Next →